What is Accuray Incorporated (ARAY) stock price today?

Accuray Incorporated (ARAY) currently trades at $0.47 per share. The stock has a market capitalization of $55.22M and a P/E ratio of —x.

Is ARAY stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Accuray Incorporated has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 5/9 and Altman Z-Score is -0.03.

What is Accuray Incorporated's revenue and earnings?

Accuray Incorporated has trailing twelve-month (TTM) revenue of $436.97M with profit margins of -8.15%. Earnings per share (EPS) is $-0.31.

Is Accuray Incorporated financially healthy?

Accuray Incorporated's Piotroski F-Score is 5/9 (moderate financial health). The Altman Z-Score of -0.03 places it in the distress.

ARAY

Accuray Incorporated

NASDAQ: ARAY · HEALTHCARE · MEDICAL DEVICES

$0.47

+10.72% today

Updated 2026-04-30

Market cap

$55.22M

P/E ratio

—

P/S ratio

0.13x

EPS (TTM)

$-0.31

Dividend yield

—

52W range

$0 – $2

Volume

1.4M

Market cap

$55.22M

P/E ratio

—

P/S ratio

0.13x

EPS (TTM)

$-0.31

Dividend yield

—

52W range

$0 – $2

Volume

1.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

3.5

Quality

2.0

Profitability

4.0

Valuation

5/9

Piotroski F-Score

Moderate

-0.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$2.53

+440.80%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Altman Z -0.03 — distress zone

- Thin margins at -8.15%

- Negative free cash flow $-17.09M

- Revenue declining -12.00% QoQ

- Debt/equity 3.83x — high leverage

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$429.91M	$447.61M	$446.55M	$458.50M	$436.97M
Net income	$-5.35M	$-9.28M	$-15.54M	$-1.59M	$-13.77M
EPS	—	—	—	—	$-0.31
Free cash flow	$-7.12M	$2.86M	$-15.51M	$-5.66M	$-17.09M
Profit margin	-1.24%	-2.07%	-3.48%	-0.35%	-8.15%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ARAY	$55.22M	34	2.7	2.0	4.0	3.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Accuray Incorporated trades at $0.47. Our Smart Value Score of 34/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -0.03, it sits in the distress. TTM revenue stands at $436.97M. with profit margins at -8.15%.

Frequently asked questions

What is Accuray Incorporated's stock price?

Accuray Incorporated (ARAY) trades at $0.47.

Is Accuray Incorporated overvalued?

Smart Value Score 34/100 (Grade F, Strong Sell).

What is the price target of Accuray Incorporated (ARAY)?

The analyst target price is $2.53, representing +440.8% upside from the current price of $0.47.

What is Accuray Incorporated's revenue?

TTM revenue is $436.97M.

Piotroski F-Score?

5/9 — moderate financial health.

Altman Z-Score?

-0.03 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.accuray.com

Quick metrics

P/S ratio0.13x

ROE-70.30%

Beta1.32

50D MA$0.46

200D MA$1.06

Shares out0.12B

Float0.11B

Short ratio—

Avg volume1.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ARAY vs LLY →ARAY vs JNJ →ARAY vs ABBV →Stock screener →